THE CEQUR DEVICE
- Key Device Features will include:
- Up to 3 days of consistent basal infusion
- On-demand bolus at push of a button
- Messages informing device status
- This product is not yet approved for use.
The CeQur device, a small discreet, wearable insulin patch infuser, is for the continuous subcutaneous delivery
of rapid acting insulin for the management of type 2 Diabetes mellitus.
The CeQur insulin delivery device is designed to meet the specific needs of people with type 2 diabetes who could benefit from intensive insulin therapy.
Its simple and discrete design may enable patients to more readily experience the benefits of intensive insulin therapy, all while remaining free from multiple daily injections.
The CeQur insulin infuser includes a disposable insulin reservoir that attaches to a reusable electronic messenger. The device easily attaches to the patient's abdominal area with a safe and secure adhesive backing. Once in place, insulin is delivered subcutaneously through a fine, soft tube or cannula from the reservoir that is changed by the patient every few days.
The CeQur insulin delivery device is designed to use just one type of insulin for both basal and bolus dosing, and will be available in multiple basal rates.
The CeQur insulin delivery device is designed to meet the specific needs of people with type 2 diabetes who could benefit from intensive insulin therapy.
Its simple and discrete design may enable patients to more readily experience the benefits of intensive insulin therapy, all while remaining free from multiple daily injections.
The CeQur insulin infuser includes a disposable insulin reservoir that attaches to a reusable electronic messenger. The device easily attaches to the patient's abdominal area with a safe and secure adhesive backing. Once in place, insulin is delivered subcutaneously through a fine, soft tube or cannula from the reservoir that is changed by the patient every few days.
The CeQur insulin delivery device is designed to use just one type of insulin for both basal and bolus dosing, and will be available in multiple basal rates.